ArticleCancers2022

Glucose and Cell Context-Dependent Impact of BMI-1 Inhibitor PTC-209 on AKT Pathway in Endometrial Cancer Cells.

Agnieszka Zaczek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.